Full Text View
Tabular View
No Study Results Posted
Related Studies
The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients
This study has been terminated.
Study NCT00001070   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: November 2, 1999   Last Updated: June 23, 2005   History of Changes

November 2, 1999
June 23, 2005
 
 
 
 
Complete list of historical versions of study NCT00001070 on ClinicalTrials.gov Archive Site
 
 
 
The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients
A Dose Escalation Study to Evaluate Tolerance and Antiviral Effect of Oral Vitamin C in Two Groups of HIV-Infected Adults

This is a study to evaluate the tolerance and antiviral effect of oral vitamin C in HIV-infected.

 
 
Interventional
Treatment, Dose Comparison, Efficacy Study
HIV Infections
Drug: Oral Vitamin C
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Terminated
50
 
 
 
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
 
 
NCT00001070
 
DATRI 017
National Institute of Allergy and Infectious Diseases (NIAID)
 
 
National Institute of Allergy and Infectious Diseases (NIAID)
April 1996

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP